Local activation of TGF-β1 at endometriosis sites

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 52, Issue 4, 2007, Pages 306-312

  Komiyama, Shin Ichi ^a   Aoki, Daisuke ^b   Komiyama, Mizuka ^b   Nozawa, Shiro ^b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Endometriosis; Plasmin; Transforming growth factor beta; Urokinase type plasminogen activator

Indexed keywords

ALPHA 2 ANTIPLASMIN; PLASMIN; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ADULT; ARTICLE; CONTROLLED STUDY; CYST FLUID; ENDOMETRIOSIS; ENDOMETRIUM CELL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADULT; CHI-SQUARE DISTRIBUTION; ENDOMETRIOSIS; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN CYSTS; PLASMIN; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA1; URINARY PLASMINOGEN ACTIVATOR;

EID: 34247601630     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Oosterlynck DJ, Meuleman C, Waer M, et al: Transforming growth factor-β activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol 1994;83:287-292
2. Whitworth CM, Mulholland J, Dunn RC, et al: Growth factor effects on endometriotial epithelial cell differentiation and protein synthesis in vitro. Fertil Steril 1994;61:91-96
3. Badawy SZ, Cuenca V, Kumar S, et al: Effect of chocolate cyst fluid on endometrioma cell growth in culture. Fertil Steril 1998;70:827-830
4. Terakawa N, Harada T: Effect of medical treatment on active lesions of peritoneal endometriosis. In Endometriosis Today. Edited by H Minaguchi. London, Parthenon Publishing Group, 1997, pp 329-333
5. Kupker W, Schultze-Mosgau A, Diedrich K: Paracrine changes in the peritoneal environment of women with endometriosis. Hum Reprod Update 1998;4:719-723
6. Rier SE, Parsons AK, Becker JL: Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis. Fertil Steril 1994;61:294-299
7. Punnonen J, Teisala K, Ranta H, et al: Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis. Am J Obstet Gynecol 1996;174: 1522-1526
8. Tseng JF, Ryan IP, Milam TD, et al: Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 1996;81:1118-1122
9. Ryan IP, Tseng JF, Schriock ED, et al: Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril 1995;63:929-932
10. Arici A, Tazuke SI, Attar E, et al: Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod 1996;2:40-45
11. Iwabe T, Harada T, Tsudo T, et al: Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis. Fertil Steril 1998;69:924-930
12. Moses HL, Yang EY, Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 1990;63:245-247
13. Sporn MB, Roberts AB (editors): Peptide Growth Factors and Their Receptors: Parts I and II. Berlin, Springer-Verlag, 1990
14. Miyazano K, Ichijo H, Heldin CH: Transforming growth factor-β: latent form, binding proteins and receptors. Growth Factors 1993;8:11-22
15. Caestecker MP, Piek E, Roberts AB: Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst 2000;92:1388-1402
16. Chegini N, Gold LI, Williams RS: Localization of transforming growth factor beta isoforms TGF-beta 1, TGF-beta 2, and TGF-beta 3 in surgically induced endometriosis in the rat. Obstet Gynecol 1994;83:455-461
17. Tamura M, Fukaya T, Enomoto A, et al: Transforming growth factor-beta isoforms and receptors in endometriotic cysts of the human ovary. Am J Reprod Immunol 1999;42: 160-167
18. Loverro G, Maiorano E, Napoli A, et al: Transforming growth factor-beta 1 and insulin-like growth factor-1 expression in ovarian endometriotic cysts: A preliminary study. Int J Mol Med 2001;7:423-429
19. Flaumenhaft R, Kojima S, Abe M, et al: Activation of latent transforming growth factor β. Adv Pharmacol 1993;24:51-76
20. Sillem M, Prifti S, Monga B, et al: Soluble urokinase-type plasminogen activator receptor is over-expressed in uterine endometrium from women with endometriosis. Mol Hum Reprod 1997;3:1101-1105
21. Guan YM, Carlberg M, Bruse C, et al: Impact of epidermal growth factor and transforming growth factor beta-1 on the release of fibrinolytic factors from cultured endometrial and ovarian endometriotic stromal cells. Gynecol Obstet Invest 2003;55:7-13
22. Lembessis P, Milingos S, Michalas S, et al: Urokinase-type plasminogen activator and insulin-like growth factor-binding protein 3 mRNA expression in endometriotic lesions and eutopic endometrium: Implications for the pathophysiology of endometriosis. Ann N Y Acad Sci 2003;997:223-228
23. Bruse C, Radu D, Bergqvist A (2004) In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue. Mol Hum Reprod 2004;10:159-166